Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,091 | 276 | 96.1% |
| Education | $164.40 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $708.67 | 49 | $0 (2023) |
| Novo Nordisk Inc | $350.47 | 24 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $239.21 | 13 | $0 (2024) |
| ABBVIE INC. | $233.61 | 25 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $201.41 | 14 | $0 (2021) |
| Allergan, Inc. | $198.30 | 12 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $186.63 | 12 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $168.98 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $142.18 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $128.70 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $574.61 | 31 | AstraZeneca Pharmaceuticals LP ($91.86) |
| 2023 | $974.90 | 61 | Kowa Pharmaceuticals America, Inc. ($466.35) |
| 2022 | $587.74 | 37 | Kowa Pharmaceuticals America, Inc. ($210.43) |
| 2021 | $961.56 | 68 | Biohaven Pharmaceuticals, Inc. ($189.00) |
| 2020 | $208.36 | 14 | Novo Nordisk Inc ($44.38) |
| 2019 | $252.88 | 19 | Sunovion Pharmaceuticals Inc. ($56.50) |
| 2018 | $404.59 | 29 | Novartis Pharmaceuticals Corporation ($87.61) |
| 2017 | $290.80 | 22 | Allergan Inc. ($74.48) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Respiratory | ||||||
| 11/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Neuropsychiatry | ||||||
| 06/26/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GI | ||||||
| 06/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neuropsychiatry | ||||||
| 06/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neuropsychiatry | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardio-renal | ||||||
| 03/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Neuropsychiatry | ||||||
| 03/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,813 | 4,743 | $249,979 | $127,400 |
| 2022 | 25 | 2,091 | 5,487 | $288,811 | $158,493 |
| 2021 | 22 | 2,017 | 5,231 | $276,428 | $148,570 |
| 2020 | 25 | 2,155 | 5,782 | $312,030 | $150,899 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 284 | 982 | $63,830 | $32,104 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 536 | $50,355 | $28,675 | 56.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 84 | 559 | $36,335 | $14,402 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $9,660 | $8,179 | 84.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 97 | 98 | $8,330 | $7,042 | 84.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 71 | $6,887 | $4,148 | 60.2% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 63 | 200 | $11,600 | $3,814 | 32.9% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 137 | 630 | $11,025 | $3,805 | 34.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 99 | $9,900 | $3,702 | 37.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 44 | 58 | $9,230 | $3,558 | 38.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 45 | 59 | $7,893 | $3,554 | 45.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 226 | 400 | $3,200 | $3,136 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 101 | 102 | $3,570 | $3,052 | 85.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $2,880 | $2,437 | 84.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 53 | 139 | $4,170 | $1,770 | 42.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 39 | $4,095 | $1,696 | 41.4% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 15 | 22 | $1,650 | $889.35 | 53.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 72 | 133 | $1,496 | $708.35 | 47.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 12 | $900.00 | $347.20 | 38.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 49 | 83 | $1,079 | $283.03 | 26.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 64 | $320.00 | $63.89 | 20.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 136 | 354 | $1,416 | $27.09 | 1.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 18 | $157.50 | $7.65 | 4.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 663 | $62,322 | $38,643 | 62.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 318 | 1,033 | $67,145 | $34,826 | 51.9% |
About Dr. Michael Dudenhoeffer, DO
Dr. Michael Dudenhoeffer, DO is a Family Medicine healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073517900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dudenhoeffer, DO has received a total of $4,255 in payments from pharmaceutical and medical device companies, with $574.61 received in 2024. These payments were reported across 281 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,091).
As a Medicare-enrolled provider, Dudenhoeffer has provided services to 8,076 Medicare beneficiaries, totaling 21,243 services with total Medicare billing of $585,362. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Jefferson City, MO
- Active Since 06/09/2005
- Last Updated 04/24/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073517900
Products in Payments
- SEGLENTIS (Drug) $455.18
- VRAYLAR (Drug) $263.91
- INGREZZA (Drug) $239.21
- NURTEC ODT (Drug) $234.19
- ZENPEP (Drug) $221.44
- Livalo (Drug) $202.08
- Ozempic (Drug) $149.48
- PERSERIS (Drug) $127.34
- XARELTO (Drug) $126.35
- ENTRESTO (Drug) $106.27
- REXULTI (Drug) $101.40
- AIRSUPRA (Drug) $91.86
- Auvelity (Drug) $84.72
- CHANTIX (Drug) $83.78
- Kerendia (Drug) $82.17
- Vascepa (Drug) $78.19
- GEMTESA (Drug) $77.30
- APTIOM (Drug) $76.52
- Victoza (Drug) $71.31
- TOUJEO (Drug) $61.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jefferson City
Dr. George Carr, Md, MD
Family Medicine — Payments: $45,033
Dr. Eric Caywood, D.o, D.O
Family Medicine — Payments: $17,382
Dustin Warbritton, D.o, D.O
Family Medicine — Payments: $13,272
Benjamin Cook, Do, DO
Family Medicine — Payments: $9,154
Dr. Michael Steenbergen, M.d, M.D
Family Medicine — Payments: $9,039
Dr. Saira Babar, M.d, M.D
Family Medicine — Payments: $7,055